Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California. more
Time Frame | THRD | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.85% | -3.39% | 0.2% |
1-Month Return | -1.3% | -1.92% | 2.72% |
3-Month Return | -10.98% | -10.54% | 7.31% |
6-Month Return | -12.36% | -4.47% | 10.44% |
1-Year Return | 14.65% | 4.06% | 27.53% |
3-Year Return | -33.24% | 0.94% | 30.88% |
Dec '20 | Dec '21 | Dec '22 | Dec '23 | |||
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Cost of Revenue | - | - | 38.00K | 35.00K | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.11,"profit":true}] | |
Gross Profit | - | - | (38.00K) | (35.00K) | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3800000,"profit":false},{"date":"2023-12-31","value":-3500000,"profit":false}] | |
Gross Margin | - | - | (Infinity%) | (Infinity%) | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}] | |
Operating Expenses | 11.12M | 19.00M | 37.71M | 43.95M | [{"date":"2020-12-31","value":25.3,"profit":true},{"date":"2021-12-31","value":43.24,"profit":true},{"date":"2022-12-31","value":85.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Operating Income | (11.12M) | (19.00M) | (37.71M) | (43.95M) | [{"date":"2020-12-31","value":-1111900000,"profit":false},{"date":"2021-12-31","value":-1900400000,"profit":false},{"date":"2022-12-31","value":-3770800000,"profit":false},{"date":"2023-12-31","value":-4395400000,"profit":false}] | |
Total Non-Operating Income/Expense | - | - | 5.11M | 26.24M | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":19.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Pre-Tax Income | (12.81M) | (29.61M) | (35.16M) | (30.82M) | [{"date":"2020-12-31","value":-1280800000,"profit":false},{"date":"2021-12-31","value":-2960900000,"profit":false},{"date":"2022-12-31","value":-3515500000,"profit":false},{"date":"2023-12-31","value":-3082400000,"profit":false}] | |
Income Taxes | (1.00K) | 10.61M | 2.55M | - | [{"date":"2020-12-31","value":-0.01,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.07,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Income After Taxes | - | - | (37.71M) | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3770800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] | |
Income From Continuous Operations | (12.81M) | (29.61M) | (35.16M) | (35.48M) | [{"date":"2020-12-31","value":-1280800000,"profit":false},{"date":"2021-12-31","value":-2960900000,"profit":false},{"date":"2022-12-31","value":-3515500000,"profit":false},{"date":"2023-12-31","value":-3547800000,"profit":false}] | |
Income From Discontinued Operations | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Net Income | (12.81M) | (29.61M) | (37.71M) | (30.82M) | [{"date":"2020-12-31","value":-1280700000,"profit":false},{"date":"2021-12-31","value":-2960900000,"profit":false},{"date":"2022-12-31","value":-3770800000,"profit":false},{"date":"2023-12-31","value":-3082400000,"profit":false}] | |
EPS (Diluted) | - | - | (1.22) | (0.98) | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-122,"profit":false},{"date":"2023-12-31","value":-98,"profit":false}] | |
These ratios help you determine the liquidity of the company. Higher is better.
THRD | |
---|---|
Cash Ratio | 41.91 |
Current Ratio | 42.50 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
THRD | |
---|---|
ROA (LTM) | -11.26% |
ROE (LTM) | -13.81% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
THRD | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.03 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.97 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
THRD | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 1.73 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Third Harmonic Bio Inc. (THRD) share price today is $11.115
Yes, Indians can buy shares of Third Harmonic Bio Inc. (THRD) on Vested. To buy Third Harmonic Bio Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in THRD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Third Harmonic Bio Inc. (THRD) via the Vested app. You can start investing in Third Harmonic Bio Inc. (THRD) with a minimum investment of $1.
You can invest in shares of Third Harmonic Bio Inc. (THRD) via Vested in three simple steps:
The 52-week high price of Third Harmonic Bio Inc. (THRD) is $16.94. The 52-week low price of Third Harmonic Bio Inc. (THRD) is $8.07.
The price-to-earnings (P/E) ratio of Third Harmonic Bio Inc. (THRD) is
The price-to-book (P/B) ratio of Third Harmonic Bio Inc. (THRD) is 1.73
The dividend yield of Third Harmonic Bio Inc. (THRD) is 0.00%
The market capitalization of Third Harmonic Bio Inc. (THRD) is $511.41M
The stock symbol (or ticker) of Third Harmonic Bio Inc. is THRD